GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (LTS:0K6R) » Definitions » Fixed Maturity Investment

Neurocrine Biosciences (LTS:0K6R) Fixed Maturity Investment


View and export this data going back to 2018. Start your Free Trial

What is Neurocrine Biosciences Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.


Neurocrine Biosciences Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.